Cargando…
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
Myasthenia gravis (MG) is an autoimmune neurological disorder characterized by defective transmission at the neuromuscular junction. The incidence of the disease is 4.1 to 30 cases per million person-years, and the prevalence rate ranges from 150 to 200 cases per million. MG is considered a classic...
Autores principales: | Dresser, Laura, Wlodarski, Richard, Rezania, Kourosh, Soliven, Betty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196750/ https://www.ncbi.nlm.nih.gov/pubmed/34064035 http://dx.doi.org/10.3390/jcm10112235 |
Ejemplares similares
-
Current Treatment of Myasthenia Gravis
por: Alhaidar, Mohammed K., et al.
Publicado: (2022) -
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update
por: Sheikh, Shuja, et al.
Publicado: (2021) -
The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021) -
Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011) -
The Epidemiology of Myasthenia Gravis in Korea
por: Lee, Hyung Seok, et al.
Publicado: (2016)